FDA Questions Lasik Informed Consent, Industry Says ‘Step Off’
The FDA’s draft guidance on labeling recommendations for Lasik patients has many shouting regulatory overreach.
The FDA’s draft guidance on labeling recommendations for Lasik patients has many shouting regulatory overreach.